honokiol has been researched along with Cancer of Kidney in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Balan, M; Briscoe, DM; Chakraborty, S; Flynn, E; Liu, K; Pal, S; Sabarwal, A; Wedel, J; Zurakowski, D | 1 |
| Balan, M; Pal, S; Rawat, L; Sabarwal, A; Sasamoto, Y | 1 |
| Balan, M; Bhowmick, S; Chakraborty, S; Hamedani, Y; Pal, S; Sabarwal, A | 1 |
| Balan, M; Chakraborty, S; Flynn, E; Pal, S; Zurakowski, D | 1 |
| Arbiser, JL; Banerjee, P; Basu, A; Pal, S | 1 |
| An, C; Li, W; Liang, H; Ma, D; Ma, L; Su, Q; Wang, Q | 1 |
| Castillo, V; Cheng, S; Eliaz, I; Sliva, D | 1 |
7 other study(ies) available for honokiol and Cancer of Kidney
| Article | Year |
|---|---|
A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation.
Topics: Animals; Apoptosis; Autophagy; Biphenyl Compounds; Cell Line, Tumor; Humans; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Lignans; Mice; Organ Transplantation; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress.
Topics: Carcinoma, Renal Cell; Heme Oxygenase-1; Humans; Kidney Neoplasms; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2023 |
Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells.
Topics: Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Liberation; Humans; Kidney Neoplasms; Lignans; Polylactic Acid-Polyglycolic Acid Copolymer; Tissue Scaffolds | 2020 |
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
Topics: Animals; Apoptosis; Biphenyl Compounds; Calcineurin Inhibitors; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Heme Oxygenase-1; Hepatocyte Growth Factor; Human Umbilical Vein Endothelial Cells; Humans; Kidney Neoplasms; Lignans; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Proto-Oncogene Proteins c-met; ras Proteins | 2017 |
The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways.
Topics: Apoptosis; Biphenyl Compounds; Calcineurin; Calcineurin Inhibitors; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Down-Regulation; Gene Expression Regulation; Genes, ras; Heme Oxygenase-1; Humans; Kidney Neoplasms; Lignans; Phosphorylation; Proto-Oncogene Mas; raf Kinases; ras Proteins; Signal Transduction; Transcriptional Activation; Transfection; Vascular Endothelial Growth Factor A | 2013 |
Honokiol suppresses renal cancer cells' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Proliferation; Epithelial-Mesenchymal Transition; Homeodomain Proteins; Humans; Kidney Neoplasms; Lignans; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplastic Stem Cells; Repressor Proteins; Signal Transduction; Tumor Burden; Zinc Finger E-box Binding Homeobox 2 | 2014 |
Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Kisspeptins; Lignans; Neoplasm Invasiveness; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Signal Transduction | 2015 |